Cutaneous Adverse Events After COVID-19 Vaccination

References

• World Health Organization. coronavirus disease (COVID-19) pandemic; 2023. Available from: https://www.who.int/europe/emergencies/situations/covid-19#:~:text=This%20led%20WHO%20to%20declare,pandemic%20on%2011%20March%202020. Accessed May 26, 2023.
   Google Scholar
• World Health Organization. COVID-19 vaccines with WHO emergency use listing; 2023. Available from: https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued. Accessed May 26, 2023.
   Google Scholar
• Database CoDC. Vaccines for COVID-19[Internet]; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html. Accessed May 26, 2023.
   Google Scholar
• Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144(6):471–484. doi:10.1161/CIRCULATIONAHA.121.056135
   PubMed Web of Science ®Google Scholar
• Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of receipt of the Ad26.COV2.S COVID-19 vaccine with presumptive guillain-barré syndrome, February-July 2021. JAMA. 2021;326(16):1606–1613. doi:10.1001/jama.2021.16496
   PubMed Web of Science ®Google Scholar
• Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of pfizer-BioNTech COVID-19 vaccine. JAMA. 2021;325(8):780–781. doi:10.1001/jama.2021.0600
   PubMed Web of Science ®Google Scholar
• Siripipattanamongkol N, Rattanasak S, Taiyaitieng C, et al. Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing. Pediatr Dermatol. 2022;39(4):601–605. doi:10.1111/pde.15074
   PubMed Web of Science ®Google Scholar
• Maronese CA, Zelin E, Avallone G, et al. Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic. Front Med. 2022;9:996288. doi:10.3389/fmed.2022.996288
   Web of Science ®Google Scholar
• Avallone G, Cavallo F, Astrua C, et al. Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience. J Eur Acad Dermatol Venereol. 2022;36(11):e876–e879. doi:10.1111/jdv.18386
   PubMed Web of Science ®Google Scholar
• Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi:10.1016/S1473-3099(21)00224-3
   PubMed Web of Science ®Google Scholar
• Grieco T, Maddalena P, Sernicola A, et al. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: an observational study. Dermatol Ther. 2021;34(6):e15153.
   PubMed Web of Science ®Google Scholar
• Rerknimitr P, Puaratanaarunkon T, Wongtada C, et al. Cutaneous adverse reactions from 35,229 doses of sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers. J Eur Acad Dermatol Venereol. 2022;36(3):e158–e161. doi:10.1111/jdv.17761
   PubMed Web of Science ®Google Scholar
• McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after moderna and pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46–55. doi:10.1016/j.jaad.2021.03.092
   PubMed Web of Science ®Google Scholar
• Català A, Muñoz-Santos C, Galván-Casas C, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022;186(1):142–152. doi:10.1111/bjd.20639
   PubMed Web of Science ®Google Scholar
• Avallone G, Quaglino P, Cavallo F, et al. SARS-CoV −2 vaccine-related cutaneous manifestations: a systematic review. Int J Dermatol. 2022;61(10):1187–1204. doi:10.1111/ijd.16063
   PubMed Web of Science ®Google Scholar
• Qaderi K, Golezar MH, Mardani A, et al. Cutaneous adverse reactions of COVID-19 vaccines: a systematic review. Dermatol Ther. 2022;35(5):e15391. doi:10.1111/dth.15391
   PubMed Web of Science ®Google Scholar
• Tuchinda P, Kulthanan K, Chularojanamontri L, Pongkittilar B, Pochanapan O, Rujitharanawong C. Disease activity of patients with chronic urticaria receiving COVID-19 vaccines. Asian Pac J Allergy Immunol. 2022. doi:10.12932/AP-160322-1345
   Google Scholar
• Acharya P, Mathur MC. Oxidative stress in alopecia areata: a systematic review and meta-analysis. Int J Dermatol. 2020;59(4):434–440. doi:10.1111/ijd.14753
   PubMed Web of Science ®Google Scholar
• Chularojanamontri L, Tuchinda P, Rujitharanawong C, et al. New-onset and exacerbated skin diseases after COVID-19 infection: a systematic review. J Dermatol. 2022;49(11):e419–e421. doi:10.1111/1346-8138.16501
   PubMed Web of Science ®Google Scholar
• Scollan ME, Breneman A, Kinariwalla N, et al. Alopecia areata after SARS-CoV-2 vaccination. JAAD Case Rep. 2022;20:1–5. doi:10.1016/j.jdcr.2021.11.023
   PubMedGoogle Scholar
• Wei N, Kresch M, Elbogen E, Lebwohl M. New onset and exacerbation of psoriasis after COVID-19 vaccination. JAAD Case Rep. 2022;19:74–77. doi:10.1016/j.jdcr.2021.11.016
   PubMedGoogle Scholar
• Wu PC, Huang IH, Wang CW, Tsai CC, Chung WH, Chen CB. New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review. Am J Clin Dermatol. 2022;23(6):775–799. doi:10.1007/s40257-022-00721-z
   PubMed Web of Science ®Google Scholar
• Tavakolpour S. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res. 2018;310(2):95–106. doi:10.1007/s00403-017-1790-8
   PubMed Web of Science ®Google Scholar
• Calabria E, Canfora F, Mascolo M, Varricchio S, Mignogna MD, Adamo D. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: a case report of pemphigus vulgaris and a literature review. Pathol Res Pract. 2022;232:153834. doi:10.1016/j.prp.2022.153834
   PubMed Web of Science ®Google Scholar
• Van Dam CS, Lede I, Schaar J, Al-Dulaimy M, Rösken R, Smits M. Herpes zoster after COVID vaccination. Int J Infect Dis. 2021;111:169–171. doi:10.1016/j.ijid.2021.08.048
   PubMed Web of Science ®Google Scholar
• Özdemir AK, Kayhan S, Çakmak SK. Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults. J Eur Acad Dermatol Venereol. 2021;35(12):e846–e847. doi:10.1111/jdv.17577
   PubMed Web of Science ®Google Scholar
• Hughes R, Lacour JP, Baldin B, Reverte M, Ortonne JP, Passeron T. Urticarial vasculitis secondary to H1N1 vaccination. Acta Derm Venereol. 2010;90(6):651–652. doi:10.2340/00015555-0950
   PubMed Web of Science ®Google Scholar
• Dash S, Behera B, Sethy M, Mishra J, Garg S. COVID-19 vaccine-induced urticarial vasculitis. Dermatol Ther. 2021;34(5):e15093. doi:10.1111/dth.15093
   PubMed Web of Science ®Google Scholar
• Ono H, Yamaguchi R, Shimizu A. Urticarial vasculitis after COVID-19 vaccination: a case report and literature review. Dermatol Ther. 2022;35(8):e15613. doi:10.1111/dth.15613
   PubMed Web of Science ®Google Scholar
• Baraldi C, Boling LB, Patrizi A, et al. Unique case of urticarial skin eruptions after COVID-19 vaccination. Am J Dermatopathol. 2022;44(3):198–200. doi:10.1097/DAD.0000000000002036
   PubMed Web of Science ®Google Scholar
• Nazzaro G, Maronese CA. Urticarial vasculitis following mRNA anti-COVID-19 vaccine. Dermatol Ther. 2022;35(3):e15282. doi:10.1111/dth.15282
   PubMed Web of Science ®Google Scholar
• Agaronov A, Makdesi C, Hall CS. Acute generalized exanthematous pustulosis induced by moderna COVID-19 messenger RNA vaccine. JAAD Case Rep. 2021;16:96–97. doi:10.1016/j.jdcr.2021.08.013
   PubMedGoogle Scholar
• O’Connor T, O’Callaghan-Maher M, Ryan P, Gibson G. Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine. JAAD Case Rep. 2022;20:14–16. doi:10.1016/j.jdcr.2021.11.028
   PubMedGoogle Scholar
• Marcelino J, Vieira J, Ferreira F, et al. Stevens-Johnson syndrome related with comirnaty® coronavirus disease 2019 vaccine. Asia Pac Allergy. 2022;12(3):e30. doi:10.5415/apallergy.2022.12.e30
   PubMed Web of Science ®Google Scholar
• Heymann WR. More than mycoplasma-induced rash and mucositis: the potential role of mycoplasma pneumoniae in Stevens-Johnson syndrome/toxic epidermal necrolysis. J Am Acad Dermatol. 2022;86(4):746–747. doi:10.1016/j.jaad.2021.12.037
   PubMed Web of Science ®Google Scholar
• Gambichler T, Boms S, Susok L, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022;36(2):172–180. doi:10.1111/jdv.17744
   PubMed Web of Science ®Google Scholar
• Hennino A, Bérard F, Guillot I, Saad N, Rozières A, Nicolas JF. Pathophysiology of urticaria. Clin Rev Allergy Immunol. 2006;30(1):3–11. doi:10.1385/CRIAI:30:1:003
   PubMed Web of Science ®Google Scholar
• Bardazzi F, Guglielmo A, Abbenante D, Sacchelli L, Sechi A, Starace MVR. New insights into alopecia areata during COVID-19 pandemic: when infection or vaccination could play a role. J Cosmet Dermatol. 2022;21(5):1796–1798. doi:10.1111/jocd.14864
   PubMed Web of Science ®Google Scholar